rEVO Biologics, Inc. IPO Research Information

rEVO Biologics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on rEVO Biologics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
rEVO Biologics, Inc.	RBIO - NASDAQ	$13.00-$15.00	$0.00	$0.00	3.6 million
Underwriter(s): Piper Jaffray, Guggenheim Securities
Co-Manager(s): Roth Capital Partners, BTIG
Industry:
Filing(s): Filed 2014-06-26 Terms Added 2014-09-04

About rEVO Biologics, Inc. (adapted from rEVO Biologics, Inc. prospectus):
They are a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions.

This description is adapted from rEVO Biologics, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as rEVO Biologics, Inc. "RBIO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.